{"AllianceGenome": "11103", "HGNC": "11103", "MIM": "601607", "_id": "6598", "_version": 1, "accession": {"genomic": ["AP000349.1", "AP000350.1", "CH471095.1", "CP068256.2", "DQ230988.1", "LC523818.1", "LC523819.1", "LC523820.1", "LC523821.1", "NC_000022.11", "NC_060946.1", "NG_009303.1", "NT_187633.1", "Y17118.1", "Y17119.1", "Y17120.1", "Y17121.1", "Y17122.1", "Y17123.1", "Y17124.1", "Y17125.1", "Y17126.1"], "protein": ["AAI17115.1", "AAI43668.1", "AAO59166.1", "AAO59167.1", "AAO59168.1", "AAS75587.1", "ABB02184.1", "BAB14784.1", "BAC77068.1", "BAG51033.1", "BAG61393.1", "BAG64629.1", "CAA09758.1", "CAA09759.1", "CAA76639.1", "CAG30467.1", "EAW59605.1", "EAW59606.1", "EAW59607.1", "EAW59608.1", "NP_001007469.1", "NP_001304875.1", "NP_001349806.1", "NP_003064.2", "Q12824.2"], "rna": ["AB017523.1", "AJ011737.1", "AJ011738.1", "AK021419.1", "AK024025.1", "AK299411.1", "AK303620.1", "AL389878.1", "AL389881.1", "AU143041.1", "AY207470.1", "AY207471.1", "AY207472.1", "AY562997.1", "BC117114.1", "BC143667.1", "BG705851.1", "CB161660.1", "CR456581.1", "HY013730.1", "NM_001007468.3", "NM_001317946.2", "NM_001362877.2", "NM_003073.5", "R37717.1"], "translation": [{"protein": "NP_001349806.1", "rna": "NM_001362877.2"}, {"protein": "AAS75587.1", "rna": "AY562997.1"}, {"protein": "AAO59167.1", "rna": "AY207471.1"}, {"protein": "BAG51033.1", "rna": "AK021419.1"}, {"protein": "CAA09759.1", "rna": "AJ011738.1"}, {"protein": "AAO59166.1", "rna": "AY207470.1"}, {"protein": "BAG61393.1", "rna": "AK299411.1"}, {"protein": "CAA09758.1", "rna": "AJ011737.1"}, {"protein": "AAO59168.1", "rna": "AY207472.1"}, {"protein": "AAI17115.1", "rna": "BC117114.1"}, {"protein": "AAI43668.1", "rna": "BC143667.1"}, {"protein": "CAG30467.1", "rna": "CR456581.1"}, {"protein": "NP_001304875.1", "rna": "NM_001317946.2"}, {"protein": "BAG64629.1", "rna": "AK303620.1"}, {"protein": "NP_001007469.1", "rna": "NM_001007468.3"}, {"protein": "BAC77068.1", "rna": "AB017523.1"}, {"protein": "NP_003064.2", "rna": "NM_003073.5"}, {"protein": "BAB14784.1", "rna": "AK024025.1"}]}, "alias": ["BAF47", "CSS3", "INI-1", "INI1", "MRD15", "PPP1R144", "RDT", "RTPS1", "SNF5", "SNF5L1", "SWNTS1", "Sfh1p", "Snr1", "hSNFS"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2023-08-15T06:00:00.000Z", "disease_label": "Coffin-Siris syndrome", "gcep": "Intellectual Disability and Autism Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0015452", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea554e80-81d2-4100-8d0e-b762ea38fe23-2023-08-15T060000.000Z", "sop": "SOP9"}, {"classification": "definitive", "classification_date": "2018-10-12T20:59:53.762Z", "disease_label": "rhabdoid tumor predisposition syndrome 1", "gcep": "Hereditary Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0012252", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d7390e7-0bb1-4ba1-b97e-7f666b52c86b-2018-10-12T205953.762Z", "sop": "SOP6"}]}, "ensembl": [{"gene": "ENSG00000099956", "protein": ["ENSP00000263121", "ENSP00000340883", "ENSP00000383984", "ENSP00000385226", "ENSP00000388489", "ENSP00000489115", "ENSP00000489445", "ENSP00000494049", "ENSP00000494283", "ENSP00000494695", "ENSP00000494757", "ENSP00000495144"], "transcript": ["ENST00000263121", "ENST00000344921", "ENST00000407082", "ENST00000407422", "ENST00000417137", "ENST00000477836", "ENST00000491967", "ENST00000634926", "ENST00000635578", "ENST00000642275", "ENST00000642727", "ENST00000643421", "ENST00000644036", "ENST00000644462", "ENST00000644467", "ENST00000644619", "ENST00000645799", "ENST00000646421", "ENST00000646723", "ENST00000646911", "ENST00000647057"], "translation": [{"protein": "ENSP00000383984", "rna": "ENST00000407422"}, {"protein": "ENSP00000340883", "rna": "ENST00000344921"}, {"protein": "ENSP00000494049", "rna": "ENST00000644036"}, {"protein": "ENSP00000494757", "rna": "ENST00000647057"}, {"protein": "ENSP00000494695", "rna": "ENST00000644619"}, {"protein": "ENSP00000263121", "rna": "ENST00000263121"}, {"protein": "ENSP00000385226", "rna": "ENST00000407082"}, {"protein": "ENSP00000388489", "rna": "ENST00000417137"}, {"protein": "ENSP00000494283", "rna": "ENST00000644462"}, {"protein": "ENSP00000489445", "rna": "ENST00000634926"}, {"protein": "ENSP00000489115", "rna": "ENST00000635578"}, {"protein": "ENSP00000495144", "rna": "ENST00000642727"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000275837", "protein": ["ENSP00000479330", "ENSP00000486780", "ENSP00000486870", "ENSP00000487092", "ENSP00000487582"], "transcript": ["ENST00000618915", "ENST00000625965", "ENST00000626269", "ENST00000629656", "ENST00000629690", "ENST00000630853", "ENST00000631333"], "translation": [{"protein": "ENSP00000487582", "rna": "ENST00000629656"}, {"protein": "ENSP00000486780", "rna": "ENST00000629690"}, {"protein": "ENSP00000479330", "rna": "ENST00000618915"}, {"protein": "ENSP00000486870", "rna": "ENST00000631333"}, {"protein": "ENSP00000487092", "rna": "ENST00000630853"}], "type_of_gene": "protein_coding"}], "entrezgene": "6598", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 16.6301262304, "exp_mis": 159.358031632, "exp_syn": 83.2803040603, "lof_z": 4.0395921070781, "mis_z": 4.50843466780104, "mu_lof": 1.16396492344e-06, "mu_mis": 1.40995213967e-05, "mu_syn": 7.15566956659e-06, "n_lof": 0.0, "n_mis": 43.0, "n_syn": 66.0, "p_li": 0.996807633610163, "p_null": 1.79385801336354e-07, "p_rec": 0.00319218700403551, "syn_z": 1.17389592132572}, "bp": 1158, "cds_end": 24176367, "cds_start": 24129356, "n_exons": 9, "nonpsych": {"exp_lof": 14.8743479737, "exp_mis": 144.056879497, "exp_syn": 75.1992002187, "lof_z": 3.78765984508731, "mis_z": 4.58297806064857, "mu_lof": 1.16396492344e-06, "mu_mis": 1.40995213967e-05, "mu_syn": 7.15566956659e-06, "n_lof": 0.0, "n_mis": 35.0, "n_syn": 58.0, "p_li": 0.994636368348609, "p_null": 7.76486145111489e-07, "p_rec": 0.00536285516524599, "syn_z": 1.24872011761721}, "nontcga": {"exp_lof": 15.2824130604, "exp_mis": 146.592096178, "exp_syn": 76.6005891385, "lof_z": 3.85635647771113, "mis_z": 4.4272589061937, "mu_lof": 1.16396492344e-06, "mu_mis": 1.40995213967e-05, "mu_syn": 7.15566956659e-06, "n_lof": 0.0, "n_mis": 39.0, "n_syn": 60.0, "p_li": 0.994935661626247, "p_null": 5.52327682343871e-07, "p_rec": 0.00506378604607096, "syn_z": 1.20096337135297}, "transcript": "ENST00000263121.7"}, "exons": [{"cdsend": 70542, "cdsstart": 23531, "chr": "22_KI270879v1_alt", "position": [[23327, 23624], [28117, 28229], [29920, 30050], [37305, 37443], [39656, 39784], [53131, 53298], [61586, 61777], [69933, 70065], [70502, 74371]], "strand": 1, "transcript": "NM_001007468", "txend": 74371, "txstart": 23327}, {"cdsend": 23834180, "cdsstart": 23787169, "chr": "22", "position": [[23786965, 23787262], [23791755, 23791867], [23793558, 23793688], [23800943, 23801081], [23803294, 23803422], [23816769, 23816936], [23825224, 23825415], [23833571, 23833703], [23834140, 23838009]], "strand": 1, "transcript": "NM_001007468", "txend": 23838009, "txstart": 23786965}, {"cdsend": 23834180, "cdsstart": 23787169, "chr": "22", "position": [[23786965, 23787262], [23791755, 23791867], [23793558, 23793688], [23800943, 23801135], [23803294, 23803422], [23816769, 23816936], [23825224, 23825415], [23833571, 23833703], [23834140, 23838009]], "strand": 1, "transcript": "NM_001317946", "txend": 23838009, "txstart": 23786965}, {"cdsend": 70542, "cdsstart": 23531, "chr": "22_KI270879v1_alt", "position": [[23327, 23624], [28117, 28229], [29920, 30050], [37305, 37497], [39656, 39784], [53131, 53298], [61586, 61777], [69933, 70065], [70502, 74371]], "strand": 1, "transcript": "NM_001317946", "txend": 74371, "txstart": 23327}, {"cdsend": 70542, "cdsstart": 23531, "chr": "22_KI270879v1_alt", "position": [[23327, 23624], [28117, 28256], [29920, 30050], [37305, 37497], [39656, 39784], [53131, 53298], [61586, 61777], [69933, 70065], [70502, 74371]], "strand": 1, "transcript": "NM_001362877", "txend": 74371, "txstart": 23327}, {"cdsend": 23834180, "cdsstart": 23787169, "chr": "22", "position": [[23786965, 23787262], [23791755, 23791894], [23793558, 23793688], [23800943, 23801135], [23803294, 23803422], [23816769, 23816936], [23825224, 23825415], [23833571, 23833703], [23834140, 23838009]], "strand": 1, "transcript": "NM_001362877", "txend": 23838009, "txstart": 23786965}, {"cdsend": 23834180, "cdsstart": 23787169, "chr": "22", "position": [[23786965, 23787262], [23791755, 23791894], [23793558, 23793688], [23800943, 23801081], [23803294, 23803422], [23816769, 23816936], [23825224, 23825415], [23833571, 23833703], [23834140, 23838009]], "strand": 1, "transcript": "NM_003073", "txend": 23838009, "txstart": 23786965}, {"cdsend": 70542, "cdsstart": 23531, "chr": "22_KI270879v1_alt", "position": [[23327, 23624], [28117, 28256], [29920, 30050], [37305, 37443], [39656, 39784], [53131, 53298], [61586, 61777], [69933, 70065], [70502, 74371]], "strand": 1, "transcript": "NM_003073", "txend": 74371, "txstart": 23327}], "exons_hg19": [{"cdsend": 24176367, "cdsstart": 24129356, "chr": "22", "position": [[24129152, 24129449], [24133942, 24134054], [24135745, 24135875], [24143130, 24143268], [24145481, 24145609], [24158956, 24159123], [24167411, 24167602], [24175758, 24175890], [24176327, 24180196]], "strand": 1, "transcript": "NM_001007468", "txend": 24180196, "txstart": 24129152}, {"cdsend": 24176367, "cdsstart": 24129356, "chr": "22", "position": [[24129152, 24129449], [24133942, 24134054], [24135745, 24135875], [24143130, 24143322], [24145481, 24145609], [24158956, 24159123], [24167411, 24167602], [24175758, 24175890], [24176327, 24180196]], "strand": 1, "transcript": "NM_001317946", "txend": 24180196, "txstart": 24129152}, {"cdsend": 24176367, "cdsstart": 24129356, "chr": "22", "position": [[24129152, 24129449], [24133942, 24134081], [24135745, 24135875], [24143130, 24143322], [24145481, 24145609], [24158956, 24159123], [24167411, 24167602], [24175758, 24175890], [24176327, 24180196]], "strand": 1, "transcript": "NM_001362877", "txend": 24180196, "txstart": 24129152}, {"cdsend": 24176367, "cdsstart": 24129356, "chr": "22", "position": [[24129152, 24129449], [24133942, 24134081], [24135745, 24135875], [24143130, 24143268], [24145481, 24145609], [24158956, 24159123], [24167411, 24167602], [24175758, 24175890], [24176327, 24180196]], "strand": 1, "transcript": "NM_003073", "txend": 24180196, "txstart": 24129152}], "generif": [{"pubmed": 11782395, "text": "The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors"}, {"pubmed": 11921280, "text": "Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors."}, {"pubmed": 11950834, "text": "SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription"}, {"pubmed": 12016208, "text": "facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity"}, {"pubmed": 12082626, "text": "Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells."}, {"pubmed": 12112529, "text": "The INI1 promoter is not hypermethylated in pediatric rhabdoid tumors."}, {"pubmed": 12138206, "text": "Data suggest that one mechanism by which INI1/hSNF5 exerts its tumor suppressor function is by mediating the cell cycle arrest due to the direct recruitment of HDAC activity to the cyclin D1 promoter, causing its repression and G(0)-G(1) arrest."}, {"pubmed": 12213194, "text": "Mutation may alter the amount of cMYC protein, but SMARCB1 is highly conserved in human solid carcinomas."}, {"pubmed": 12548550, "text": "INI1 is a tumor suppressor gene gone awry in malignant rhabdoid tumor cells"}, {"pubmed": 12892231, "text": "germline hSNF5 mutation is associated with rhabdoid predisposition syndrome"}, {"pubmed": 14526201, "text": "alternative splicing and role implicated in interaction with HIV-1"}, {"pubmed": 14604992, "text": "hSNF5-induced cellular senescence is mediated by the p16(INK4a)/pRb pathway"}, {"pubmed": 14963118, "text": "transdominant mutant S6, harboring the minimal integrase interaction domain of INI1/hSNF5, blocks HIV-1 particle production but not that of the other retroviruses in 293T cells"}, {"pubmed": 14990991, "text": "in human cells, SWI/SNF enzyme complex formation and the expression of many BRG1-dependent genes are independent of INI1."}, {"pubmed": 15101046, "text": "Novel SMARCB1 germ-line deletions in neonatal congenital kidney rhabdoid tumors and brain primitive neuroectodermal tumors patients."}, {"pubmed": 15150092, "text": "hSNF5/INI1 may modulate the cell cycle control and cytoskeleton organization through the regulation of the retinoblastoma protein-E2F and Rho pathways."}, {"pubmed": 15175083, "text": "somatic point mutations of hSNF5/INI1 do not play a role in the pathogenesis of choroid plexus papilloma"}, {"pubmed": 15489652, "text": "Immunohistochemical analysis of hSNF5/INI1 gene distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors by assessing loss of INI1 expression in rhabdoid tumors."}, {"pubmed": 15589835, "text": "INI1 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfere with virus integration."}, {"pubmed": 15642401, "text": "Mutated in choroid plexus carcinoma."}, {"pubmed": 15761491, "text": "INI1 immunohistochemistry is a relatively simple, sensitive, and specific technique for distinguishing malignant rhabdoid tumor and atypical teratoid/rhabdoid tumor from composite rhabdoid tumor."}, {"pubmed": 15769941, "text": "hSNF5 activates the mitotic checkpoint through the p16INK4a-cyclinD/CDK4-pRb-E2F pathway, whereas loss of hSNF5 function in malignant rhabdoid tumor-derived cells leads to polyploidization and chromosomal instability."}, {"pubmed": 15796965, "text": "The tumor suppressor gene hSNF5 was lacking in the malignant rhabdoid tumor of the liver."}, {"pubmed": 15899790, "text": "SMARCB1/INI1 inactivation to 6 of 11 cases of epithelioid sarcoma is shown by real-time quantitative PCR analysis of mRNA expression and by SMARCB1/INI1 immunohistochemistry."}, {"pubmed": 15981100, "text": "Tumors harbored such hSNF5/INI1 aberrations as germline single base deletion (492/6 delC) and missense mutation (C157T) together with LOH 22q or homozygous deletion. Cyclin D1 was overexpressed in the same tumors."}, {"pubmed": 15993274, "text": "INI1hSNF5 and PARVG do not seem to be the tumor suppressor genes involved in oligodendroglioma development and progression"}, {"pubmed": 16154112, "text": "This strongly suggests that the SNF5 homology domain presents species-specific functions."}, {"pubmed": 16219292, "text": "INI1/hSNF5/BAF47 could be recruited to the region of cellular oncogene c-fos promoter to reduce histone acetylation"}, {"pubmed": 16267391, "text": "All conserved domains of INI1/hSNF5/BAF47 are needed for CSF1 transcription and INI1/ hSNF5/BAF47 is recruited to the region of the CSF1 promoter."}, {"pubmed": 16288006, "text": "hSNF5 binds the p16INK4a and p21CIP/WAF1 promoters, suggesting that it directly regulates transcription of these genes. hSNF5 loss may influence the regulation of multiple CDK inhibitors involved in replicative senescence."}, {"pubmed": 16528370, "text": "Immunohistochemistry to assess expression of SMARCB1/INI1 may be useful in the diagnosis of rhabdoid tumors of the CNS, kidneys and soft tissue."}, {"pubmed": 16568092, "text": "BAF155 and potentially INI1 are substrates for Akt phosphorylation"}, {"pubmed": 16772295, "text": "by interacting with IN, SNF5/Ini1 interferes with early steps of HIV-1 infection"}, {"pubmed": 16889668, "text": "While INI1 is dispensable for HIV-1 transduction, it can facilitate HIV-1 transcription by enhancing Tat function."}, {"pubmed": 16912184, "text": "Relationship between Rb and Ini1 in tumor suppression indicate that Ini1 plays a role in maintaining the morphologic and functional differentiation of corticotrophic cells."}, {"pubmed": 17357086, "text": "INI1 is the predisposing gene in familial schwannomatosis."}, {"pubmed": 17376508, "text": "results demonstrate that deletions and mutations of the INI1 gene can occur in rare composite rhabdoid tumors of adulthood"}, {"pubmed": 17486366, "text": "Inactivation of the SMARCB1/INI1 gene is associated with rhabdoid tumor"}, {"pubmed": 17616514, "text": "Knockdown experiments performed in human ALL cell lines confirmed that lower SMARCB1 expression increased prednisolone resistance."}, {"pubmed": 17669367, "text": "Gene expression profiling of the hSNF5-down-regulated cells by cDNA microarray analysis revealed that a limited number of p53-responsive genes, especially p21, were up-regulated"}, {"pubmed": 17699849, "text": "Microarray studies indicated that INI1 activated IFN-stimulated genes at early time points and senescence markers at late time points and repressed mitotic genes such as Polo like kinase 1 (PLK1), selectively in rhabdoid cells."}, {"pubmed": 17717433, "text": "Loss of INI1 expression may rarely be encountered in tumors undergoing malignant transformation, but this is accompanied by mutation in the INI1 gene."}, {"pubmed": 17922027, "text": "hSNF5/INI1 cooperates with C/EBPbeta and PPARgamma2 transcriptional regulators to activate the expression of adipocyte-specific genes."}, {"pubmed": 18072270, "text": "The latter observation suggests that a four-hit mechanism involving the SMARCB1 and NF2 genes may be implicated in schwannomatosis-related tumorigenesis."}, {"pubmed": 18087273, "text": "Transmission of a germline INI1-mutation in a rhabdoid tumor predisposition syndrome family via nonpenetrant males."}, {"pubmed": 18236049, "text": "present genetic evidence that the meningioma is not a recurrence or metastasis of the AT/RT and not due to the INI1 mutation, but is a radiation-induced tumour."}, {"pubmed": 18262058, "text": "SMARCB1 may be a tumor suppressor gene for malignant rhabdoid tumor."}, {"pubmed": 18266055, "text": "two single nucleotide polymorphisms at the hSNF5/INI1 gene in exon 4 and exon 9 were found in controls and in Acute myeloid leukemia patients"}, {"pubmed": 18285426, "text": "In all affected individuals with SMARCB1 mutations and available tumour tissue, bi-allelic somatic inactivation of the NF2 gene, was detected."}, {"pubmed": 18327209, "text": "the absence of INI1 expression is not necessarily predictive of rhabdoid histopathology but remains associated with aggressive behavior in renal medullary carcinoma."}, {"pubmed": 18422762, "text": "These results confirm a role for INI1/SMARCB1 in multiple schwannoma syndromes and suggest that a different pathway of tumorigenesis occurs in solitary, sporadic tumors."}, {"pubmed": 18580682, "text": "Lack of SMARCB1 expression may be associated with rhabdoid features. The immunohistochemical result of the SMARCB1 expression is not an absolute diagnostic criteria for malignant rhabdoid tumor."}, {"pubmed": 18647326, "text": "SMARCB1 is a tumor suppressor for schwannomas in the context of familial disease."}, {"pubmed": 18676838, "text": "inhibition of migration is another crucial tumor suppressor function of hSNF5/INI1, in addition to its previously described functions in proliferation and differentiation"}, {"pubmed": 18710953, "text": "Snf5-deficient primary cells do not show altered sensitivity to DNA damaging agents, defects in gamma-H2AX induction, or an abrogated DNA damage checkpoint."}, {"pubmed": 18973917, "text": "Analysis of alterations in the SMARCB1/INI1 gene may be a useful for distinguishing proximal-type epithelioid sarcoma from malignant rhabdoid tumor."}, {"pubmed": 18985520, "text": "of INI1 immunostaining is a reliable marker for rhabdoid tumours and atypical teratoid/rhabdoid tumours in children."}, {"pubmed": 18997735, "text": "alterations of the INI1 gene with consequent loss of expression identified a population of undifferentiated sarcomas lacking classic rhabdoid morphology in young patients, with evidence of favorable survival"}, {"pubmed": 19033866, "text": "Immunostaining for INI1 can be used to confirm the diagnosis of epithelioid sarcoma in the appropriate context."}, {"pubmed": 19124645, "text": "a germline 2631 bp duplication that includes exon 6 of SMARCB1 in a unique family with a four generation history of MRT predisposition and schwannomatosis."}, {"pubmed": 19141382, "text": "Loss of expression of INI1 is frequent in the conventional and large cell subtypes of epithelioid sarcoma and can be used as a diagnostic marker, but it has no prognostic impact."}, {"pubmed": 19221051, "text": "Study show that the C-terminal SET domain of MLL3 and MLL4 directly interacts with INI1, an integral subunit of Swi/Snf."}, {"pubmed": 19221586, "text": "Results show that the imprinted cell cycle inhibitor CDKN1C is a downstream target for SMARCB1 and is transcriptionally activated by increased histone H3 and H4 acetylation at the promoter."}, {"pubmed": 19276269, "text": "INI1 is the primary tumor suppressor gene involved in the development of rhabdoid tumors with no second locus identified."}, {"pubmed": 19276269, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19305156, "text": "Better understanding of the mechanisms by which mutation of SMARCB1 drive oncogenesis has the potential to identify novel therapeutic approaches for rhabdoid tumors and related cancers."}, {"pubmed": 19320657, "text": "Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterations"}, {"pubmed": 19328320, "text": "Mutations may be present in familial and sporadic schwannomaatosis."}, {"pubmed": 19351817, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19398554, "text": "INI1 residues involved in multimerization overlap with HIV-1 integrase-binding and nuclear export domains and are required for nuclear retention and co-localization with IN."}, {"pubmed": 19480937, "text": "Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition."}, {"pubmed": 19503603, "text": "study indicates HIV-1 integrase & INI1/hSNF5 bind SAP18 & recruit components of Sin3a-HDAC1 complex into HIV-1 virions; HIV-1 virion-associated HDAC1 is required for efficient early post-entry events, indicating novel role for HDAC1 in HIV-1 replication"}, {"pubmed": 19515827, "text": "These results demonstrate the opposing effects of Ini1/hSNF5-containing SWI/SNF complexes on basal and Tat-dependent transcriptional activity of the HIV-1 promoter."}, {"pubmed": 19582488, "text": "a familial SMARCB1 mutation has a role in schwannomatosis associated with multiple meningiomas [case report]"}, {"pubmed": 19683621, "text": "Direct evidence is reported of mutational inactivation of SMARCB1."}, {"pubmed": 19805520, "text": "show that the human SWI/SNF component human SNF5 (hSNF5) interacts with UV damage recognition factor XPC and colocalizes with XPC at the damage site."}, {"pubmed": 19808872, "text": "SNF5 may be an important marker for human melanoma progression and prognosis as well as a potential therapeutic target."}, {"pubmed": 19902524, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19902524, "text": "Patients with germline mutation of SMARCB1 manifest at an early age and have a very high risk for progression to rhabdoid tumors."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20003390, "text": "nine distinct pathogenic SMARCB1 mutations were identified in a total of 19 possible rhabdoid tumors"}, {"pubmed": 20078948, "text": "PIH1D1 may stabilize SNF5 by attenuating its proteasome degradation pathway."}, {"pubmed": 20118769, "text": "Polyphenotypic immunohistochemical expression and focal loss of INI-1 protein in the rhabdoid areas of rhabdoid glioblastomas distinguished them from epithelioid glioblastomas."}, {"pubmed": 20305614, "text": "there is a post-transcriptional SMARCB1/INI1 regulatory mechanism in the tumor cells of synovial sarcoma"}, {"pubmed": 20472658, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20472658, "text": "SMARCB1 is not a major contributor to multiple meningioma disease."}, {"pubmed": 20506188, "text": "The interaction of RUNX1 with the SWI/SNF BRG1 and INI1 to control hematopoietic-specific gene expression is described."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20829602, "text": "These results suggest that the SWI/SNF complex is involved in human papillomavirus E2-driven transcription and DNA replication via interaction with E2."}, {"pubmed": 20930055, "text": "A germline missense mutation in exon 2 of SMARCB1 predisposes to multiple meningiomas and a four-hit mechanism of tumour suppressor gene inactivation, involving SMARCB1 and NF2, might be operative in familial multiple meningiomas associated meningiomas."}, {"pubmed": 20932739, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21057957, "text": "A likely role is revealed for SMARCB1/INI1 in a subset of chordomas with aggressive features."}, {"pubmed": 21108436, "text": "Approximately one-third of newly diagnosed patients with rhabdoid tumor have an underlying genetic predisposition to tumors due to a germline SMARCB1 alteration. Families may demonstrate incomplete penetrance and gonadal mosaicism"}, {"pubmed": 21127945, "text": "loss of INI1 could induce the chromosomal instability that might be responsible for the genesis of teratoid/rhabdoid tumor."}, {"pubmed": 21159066, "text": "[review] Chromosome 22 mutation of SNF/INI1 causes its protein product to participate in the chromatin remodeling mechanism of this highly malignant atypical teratoid/rhabdoid tumor."}, {"pubmed": 21159874, "text": "hSNF5 negative mutant S6 inhibited the early stages of HIV-1 assembly."}, {"pubmed": 21208904, "text": "The results show a high proportion of hSNF5/INI1 germline mutations in patients with RT that can be found at any age and up to 60% in the youngest patients."}, {"pubmed": 21240060, "text": "Loss of INI1 immunohistochemical expression in glioblastoma may be indicating an underlying molecular aberration accounting for the more aggressive clinical behaviour."}, {"pubmed": 21255467, "text": "results suggest that patients with schwannomas have a significant probability of carrying a SMARCB1 mutation."}, {"pubmed": 21494030, "text": "genetic association studies: Results suggest that alterations of the SNF5 gene are rare in hematological neoplasms with chromosome 22 abnormalities."}, {"pubmed": 21521802, "text": "These results indicated that Aurora A is a direct downstream target of INI1/hSNF5-mediated repression in RT cells and that loss of INI1/hSNF5 leads to aberrant overexpression of Aurora A in these tumors, which is required for their survival."}, {"pubmed": 21613800, "text": "The hemiallelic loss of INI1 gene causing reduced expression of INI1 protein probably does not have a major impact in the progression of GIST."}, {"pubmed": 21637919, "text": "RB1CC1 essentially requires binding with hSNF5 to activate the p16 promoter."}, {"pubmed": 21705046, "text": "Our results suggest that some CDC cases might be associated with genetic alterations involving the SMARCB1/INI1 gene"}, {"pubmed": 21809989, "text": "Immunohistochemical reactivity for BAF47 is clinically useful in distinguishing medullo-blastomas from atypical teratoid/rhabdoid tumors."}, {"pubmed": 22020042, "text": "This study reveals that a novel yet unidentified posttranscriptional regulatory mechanism(s) for INI1 protein synthesis exists in Atypical teratoid/rhabdoid tumor tumor cells."}, {"pubmed": 22038540, "text": "Data suggest that the SMARCB1 exon 2 missense mutation in this family predisposes to the development of meningiomas as well as schwannomas, and that this mutation preferentially induces cranial meningiomas located at the falx cerebri."}, {"pubmed": 22082606, "text": "We report the presence of a novel germline mutation in the SMARCB1/INI1 gene in a patient with multiple schwannomas and in 3 of her children, 2 of whom were diagnosed with atypical teratoid/rhabdoid tumors of the brain."}, {"pubmed": 22434358, "text": "SMARCB1 mutations are found in a significant proportion of schwannomatosis patients."}, {"pubmed": 22479537, "text": "chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44"}, {"pubmed": 22490415, "text": "INI1 plays a key role in gastric carcinogenesis by affecting proliferation, apoptosis and invasion."}, {"pubmed": 22544318, "text": "SNF5 recruits the SWI/SNF complex to the BIN1 promoter, and that the marked reduction of BIN1 expression in RT correlates with decreased SWI/SNF occupancy."}, {"pubmed": 22614000, "text": "SMARCB1 inactivation, occasionally associated with NF2 deletion, might have oncogenic effects in peripheral nerves."}, {"pubmed": 22672440, "text": "This immunohistochemistry was used to identify whether loss of INI1 protein expression occurred in the central nervous system primitive neuroectodermal tumors and pineoblastomas"}, {"pubmed": 22686875, "text": "neoplastic cells showed complete loss of SMARCB1/INI1 expression in all six cases of Renal medullary carcinoma"}, {"pubmed": 22698742, "text": "Both BEX2 and INI1/hSNF5 mainly localized in cell nucleus."}, {"pubmed": 22752724, "text": "SMARCB1 mutations associated with familial schwannomatosis with meningiomas"}, {"pubmed": 22797305, "text": "Sequenced the exomes of 35 rhabdoid tumors, aggressive cancers characterized by biallelic loss of SMARCB1 of the chromatin remodeling complex. Identified an extremely low rate of mutation, with loss of SMARCB1 being essentially the sole recurrent event."}, {"pubmed": 22949514, "text": "Data suggest that these tumors develop through a mechanism that is distinct from that of rhabdoid tumors in which SMARCB1 protein is completely absent in tumor cells."}, {"pubmed": 23060122, "text": "Report a high percentage of SMARCB1 alterations in epithelioid sarcoma."}, {"pubmed": 23074045, "text": "Data indicate that in atypical teratoid/rhabdoid tumor (AT/RT), high-resolution genomic analysis by MIP SNP assay confirmed a wide absence of genomic alterations other than SMARCB1."}, {"pubmed": 23174932, "text": "Loss of SMARCB1 expression in epithelioid sarcoma is caused neither by DNA hypermethylation nor by post-translational modifications. Most likely it is a result of the microRNA destruction of SMARCB1 mRNA."}, {"pubmed": 23245672, "text": "uniformly decreased INI1 immunoreactivity is highly sensitive and specific for synovial sarcoma."}, {"pubmed": 23348212, "text": "These data suggest that inactivation of SMARCB1 may play a role in the pathogenesis of renal medullary carcinoma."}, {"pubmed": 23364536, "text": "Our studies show that hSNF5 regulates only a subset of p53 target genes, including p21 and NOXA, in MRT cell lines. We also show that hSNF5 reexpression modulates SWI/SNF complex levels at the transcription start site (TSS)"}, {"pubmed": 23435428, "text": "SNF5 is essential for regulating Wnt/beta-catenin pathway target expression."}, {"pubmed": 23593299, "text": "In HIV-1 integration, the integrase binding domain of INI1 inhibits the 3' processing reaction but does not interfere with specific viral DNA binding."}, {"pubmed": 23799881, "text": "These results demonstrate that a severe defect in HIV-1 integrase-human INI1 interaction is associated with production of defective particles and a subsequent defect in post-entry events."}, {"pubmed": 23815551, "text": "SMARCB1, SMARCA4, or ARID1B were mutated in 20 out of 49 Coffin-Siris syndrome patients."}, {"pubmed": 23851497, "text": "Results indicate that hSNF5 affects both the stability and the activity of DNM2, uncovering an unexpected role of hSNF5 in modulating endocytosis, and open new perspectives in understanding the role of hSNF5 in tumour genesis."}, {"pubmed": 23904343, "text": "The switch/sucrose non-fermenting complex has a tumor-suppressive function, and that switch/sucrose non-fermenting gene deficiencies may affect the properties of cancer cells, which could be of value for the development of novel therapeutic strategies."}, {"pubmed": 24075062, "text": "SMARCB1 is a useful tumor marker for differential diagnosis of musculoskeletal tumors."}, {"pubmed": 24123847, "text": "Loss of SMARCB1 gene is associated with rhabdoid tumors."}, {"pubmed": 24204904, "text": "Re-expression of SNF5 in MRT cells."}, {"pubmed": 24285714, "text": "these findings define a leukemia maintenance function for SWI/SNF that is linked to enhancer-mediated gene regulation"}, {"pubmed": 24286138, "text": "SMARCB1/INI1-dysregulation and genetic hot-spots on the long arm of chromosome 22 might play an important role in the colorectal cancer metastatic behavior."}, {"pubmed": 24287458, "text": "miR193a-5p may have an important role in the inhibition of SMARCB1 mRNA expression."}, {"pubmed": 24327545, "text": "Loss of SMARCB1 protein expression in epithelioid sarcoma is due to the epigenetic mechanism of gene silencing by oncomiRs."}, {"pubmed": 24418192, "text": "Homozygous deletions or gene mutations in CNTNAP2 and SMARCB1 associated with malignant rhabdoid tumors."}, {"pubmed": 24503755, "text": "Case Report/Review: loss of SMARCB1 in rhabdoid carcinomas of the gastrointestinal tract is associated with a highly aggressive course."}, {"pubmed": 24525513, "text": "Case Report: leiomyoma associated with a germline SMARCB1 mutation in schwannomatosis."}, {"pubmed": 24585572, "text": "Study confirms the shared pathogenesis of proximal and distal Epithelioid sarcomas, showing consistent SMARCB1 homozygous deletions."}, {"pubmed": 24832165, "text": "Case Reports: sinonasal carcinoma with loss of nuclear SMARCB1 expression."}, {"pubmed": 24853101, "text": "this review discusses normal functions of SMARCB1 and the SWI/SNF complex as well as mechanistic and potentially therapeutic insights that have emerged."}, {"pubmed": 24933152, "text": "Whereas SMARCB1 alone seems to account for rhabdoid disease, there is likely to be substantial heterogeneity in schwannomatosis even for familial disease."}, {"pubmed": 24983247, "text": "Mutations in SMARCB1 occurred in areas of chromosomal copy loss in chordoma tumor samples."}, {"pubmed": 25007146, "text": "Inactivation of the SMARCB1 tumor-suppressor gene appears to be involved in the pathogenesis of a subset of sinonasal carcinomas."}, {"pubmed": 25009291, "text": "SNF5 loss dramatically alters SWI/SNF complex composition and prevents formation of complexes required for cellular differentiation."}, {"pubmed": 25081545, "text": "BAF complex gene SMARCB1 is mutated in Coffin-Siris syndrome patients."}, {"pubmed": 25103069, "text": "in pancreatic undifferentiated rhabdoid carcinomas SMARCB1 loss is restricted to the anaplastic monomorphic subtype"}, {"pubmed": 25168959, "text": "Genotype-phenotype correlation of Coffin-Siris syndrome caused by mutations in SmarCB1 gene."}, {"pubmed": 25200863, "text": "Of the 23 epithelioid sarcoma cases, 19 showed a loss of PBRM1, and 18 a loss of INI1. In 17 cases, loss of both proteins was observed. The pattern of PBRM1 expression was similar to that of INI1: not correlated with changes in cellular morphology."}, {"pubmed": 25246033, "text": "This a review of the histopathologic features of malignant rhabdoid tumor (MRT) and the importance and significance of loss of expression of SMARCB1 in both MRT and nonrhabdoid tumors. [Review]"}, {"pubmed": 25271443, "text": "our data unravel differential roles for SWI/SNF subunits in muscle differentiation, with BAF47 playing a dual role both in the permanent cell cycle exit and in the regulation of muscle-specific genes."}, {"pubmed": 25479928, "text": "analyzed the frequency of ERG and SALL4 expressions in 80 SMARCB1/INI1-deficient tumors"}, {"pubmed": 25496315, "text": "We report, for the first time, co-inactivation and frequent mutations of SMARCB1, SMARCA2 and PBRM1 in MRTs."}, {"pubmed": 25559666, "text": "Taken together, these data indicate that Nef is a critical viral protein for incorporating nascent proviral DNA into host chromosomes in resting peripheral mononuclear leukocytes and that this occurs through interaction with INI1."}, {"pubmed": 25649007, "text": "INI1-retained Small cell undifferentiated may be not prognostically unfavorable"}, {"pubmed": 25651469, "text": "We conclude that SMARCB1-deficient vulvar neoplasms chiefly comprise epithelioid sarcoma and myoepithelial carcinoma"}, {"pubmed": 25663425, "text": "SMARCB1 loss in ascites cells is associated with abdominal rhabdoid tumor."}, {"pubmed": 25754356, "text": "Identification of SMARCB1 mutations adds to the growing literature regarding the role of epigenetic control mechanisms in melanoma progression and therapeutic resistance."}, {"pubmed": 26073604, "text": "Mutations in INI1 that cause schwannomatosis target a hitherto unidentified N-terminal winged helix DNA binding domain that is also present in the BAF45a/PHF10 subunit of the SWI/SNF complex."}, {"pubmed": 26109171, "text": "a novel INI1(+) ATRT-like subtype among Taiwanese pediatric patients"}, {"pubmed": 26171919, "text": "Myoepithelioma-like tumors of the vulvar region deficient in SMARCB1 constitute a distinct group of tumors."}, {"pubmed": 26261664, "text": "Case Report: SMARCB1-deficient vulvar sarcoma expressing ERG and FLI1."}, {"pubmed": 26342593, "text": "we report on a new Italian family with recurrence of SMARCB1 germ-line deletion in two siblings due to gonadal mosaicism"}, {"pubmed": 26342709, "text": "study describes a rare case of a novel nonsense mutation in SMARCB1 that causes schwannomatosis; first report of a SMARCB1 mutation in a schwannomatosis family exhibiting (unilateral) vestibular schwannoma; results constitute a significant finding given that SMARCB1 mutations can cause both conditions via a four-hit mechanism"}, {"pubmed": 26350979, "text": "Macaca mulatta SMARCB1 showed 23 single nucleotide differences compared to the human ortholog and the amino acid sequence is 100% conserved between human and simian INI1."}, {"pubmed": 26364901, "text": "Missense mutation in SMARCB1 gene is associated with Coffin-Siris phenotype, and schwannomatosis."}, {"pubmed": 26433572, "text": "Our study, the first comprehensive analysis of RMC, supports a pivotal role for SMARCB1 in its development."}, {"pubmed": 26520417, "text": "Reduced expression of SMARCB1 immunoreactivity was found to be highly sensitive and specific for synovial sarcoma."}, {"pubmed": 26965049, "text": "CAPZB is involved in tumor progression in cases of epithelioid sarcoma (EpiS), irrespective of the INI1 expression, and may be a potential therapeutic target. The paradoxical relationship between the tumor suppressor INI1 and the oncoprotein CAPZB in the pathogenesis of EpiS remains to be clarified"}, {"pubmed": 27111394, "text": "Low SNF5 expression is associated with Hepatocellular Carcinoma."}, {"pubmed": 27184481, "text": "INI1 loss occurs rarely in colorectal carcinoma, where it is associated with higher grade, larger tumor size, poorer survival, mismatch repair deficiency, and BRAFV600E mutation."}, {"pubmed": 27218413, "text": "We conclude that in the context of 22q11-12 regional alterations present in SMARCB1-deleted tumors, simultaneous EWSR1 involvement may be misinterpreted as equivalent to EWSR1 rearrangement. A detailed clinicopathologic correlation and supplementing the EWSR1 FISH assay with complementary methodology is mandatory for correct diagnosis"}, {"pubmed": 27223121, "text": "Our results suggest a general role of miR-206,-381, and 671-5p in SMARCB1 gene silencing of epithelioid sarcomas(ES) , extraskeletal myxoid chondrosarcomas , malignant peripheral nerve sheath tumors and synovial sarcomas . In the future, miR-765 could possibly be a diagnostic tool for ES because of its 97% specificity and 80% sensitivity."}, {"pubmed": 27246730, "text": "The common loss of INI1 expression in rhabdoid and non-rhabdoid tumors will also open new therapeutic doors by developing targeted therapy strategies which may help to consolidate an initial treatment response to conventional radiochemotherapy."}, {"pubmed": 27261671, "text": "Rpt1 domain of INI1 may participate in ubiquitin recognition or binding with ubiquitin or ubiquitin related proteins."}, {"pubmed": 27267444, "text": "INI1 re-expression suppresses cell proliferation and MYC-potentiated transformation."}, {"pubmed": 27339451, "text": "reporting involvement of the SWI/SNF complex in the dedifferentiation process of a variety of epithelial neoplasms in different organs, including the urinary tract, and association with aggressive clinical course"}, {"pubmed": 27356182, "text": "Deletions in INI1 gene is associated with Small cell undifferentiated hepatoblastomas."}, {"pubmed": 27380723, "text": "cribriform neuroepithelial tumor showed large heterozygous 22q deletions (9/10) and SMARCB1 mutations."}, {"pubmed": 27466490, "text": "BZ was included in this study as a proteasome inhibitor because loss of SMARCB1 led to increased phosphorylation in rhabdoid tumo.rs Administration of BZ very strongly decreased cell proliferation of all three cell lines being the most cytotoxic compound of all tested substances"}, {"pubmed": 27503929, "text": "SWI/SNF complexes lacking SMARCB1 are vital determinants of drug sensitivity, not just to TOP2A-targeted agents, but to the much broader range of cancer drugs effluxed by ABCB1."}, {"pubmed": 27558426, "text": "Interfering INI1 or the INI1-SAP18 interaction leads to the impairment of these processes."}, {"pubmed": 27635948, "text": "Our results confirm the pathogenic involvement of SMARCB1/INI1 in childhood chordoma"}, {"pubmed": 27732747, "text": "We report two cases of SMARCB1-deficient tumours located in the meninges and occurring in young adults"}, {"pubmed": 27733182, "text": "Case Report: renal cell carcinoma with Xp11.2 translocation, TFE3 rearrangement and SMARCB1 inactivation in end stage renal disease patient."}, {"pubmed": 27941797, "text": "SMARCB1 is required for the integrity of SWI/SNF complexes."}, {"pubmed": 28069272, "text": "For the first time, we performed analysis of DNA methylation in SMARCB1/INI1-deficient sinonasal carcinomas, reporting on significantly higher methylation of RASSF1 gene in this neoplasm."}, {"pubmed": 28109176, "text": "Interactions have been indicated between SMARCB1/INI1 protein and key proteins in various pathways related to tumor proliferation and progression."}, {"pubmed": 28228393, "text": "These highly mobile and invasive cells no longer depend on KRAS signaling and rely on the aberrant activation of mesenchymal programs regulated by the chromatin remodeling factor SMARCB1. Mouse models showed that Smarcb1 ablation could intensify cancer spread; conversely, restoring Smarcb1 slowed tumor growth and restored the cells to their less invasive, epithelial form"}, {"pubmed": 28235567, "text": "SNF5 is indispensable for CRIF1-enhanced p53 activity and its function in the suppression of cell cycle arrest in human cancer cells."}, {"pubmed": 28291122, "text": "SMARCB1-deficient sinonasal carcinoma represents an emerging poorly differentiated/undifferentiated sinonasal carcinoma."}, {"pubmed": 28338502, "text": "Biallelic alterations in the INI1 gene were identified in 4 of the 5 cases of atypical teratoid/rhabdoid tumors. Three of the 4 cases harbored 2 different mutations, presumably on different alleles (compound heterozygous mutations), and 1 case of which had a splice-site mutation."}, {"pubmed": 28365909, "text": "The mosaic loss of INI1 expression is a reliable marker of schwannomatosis."}, {"pubmed": 28368924, "text": "The epithelioid variant of schwannoma is rare, and loss of SMARCB1/INI1 expression has been observed in a subset of cases. Our aim was to further define the clinicopathologic features and to evaluate SMARCB1/INI1 deficiency in a large cohort of 65 epithelioid schwannomas diagnosed between 2002 and 2015"}, {"pubmed": 28420320, "text": "All pediatric non-vestibular schwannomas tested (23/23) showed retained nuclear expression of SMARCB1/INI1."}, {"pubmed": 28438634, "text": "Here, the authors first confirmed that SWIRM domain of BAF155 is responsible for its interaction with BAF47 and then narrowed down the SWIRM-binding region in BAF47 to the Repeat 1 (RPT1) domain."}, {"pubmed": 28620005, "text": "the malignancy risk in schwannomatosis is not well defined but may include an increased risk of malignant peripheral nerve sheath tumor in SMARCB1 Imaging protocols are also proposed for SMARCB1 and LZTR1 schwannomatosis and SMARCE1-related meningioma predisposition."}, {"pubmed": 28620006, "text": "The outcome following a diagnosis of any of these tumors is often poor, and the value of surveillance is unknown. International efforts to determine surveillance protocols are underway, and preliminary recommendations are made for carriers of SMARCB1 and SMARCA4 mutations."}, {"pubmed": 28716547, "text": "BAF57, BAF60a and SNF5 might act as novel pro-senescence factors in both normal and tumor human skin cells"}, {"pubmed": 28722703, "text": "Intronic hotspot variant of SMARCB1 was identified in atypical teratoid and rhabdoid tumors of two patients.  This cryptic variant was absent in the germline DNA of both patients."}, {"pubmed": 28825187, "text": "Loss of SMARCB1/INI1 expression is considered to be a hallmark for childhood chordomas."}, {"pubmed": 28863077, "text": "Of the 34 undifferentiated endometrial carcinomas examined, 17 (50%) exhibited SWI/SNF complex inactivation, with 11 tumors showing complete loss of both ARID1A and ARID1B, 5 showing complete loss of BRG1 and 1 showing complete loss of INI1. Ten of the remaining 17 undifferentiated carcinomas showed the following alterations: 5 tumors (15%) showed loss of ARID1A only with intact ARID1B, BRG1, and INI1 expression."}, {"pubmed": 28945250, "text": "SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters."}, {"pubmed": 28974397, "text": "The genomic profiles of the tumors from patients with urothelial carcinoma (UC) revealed a population of tumors driven by complete loss of SMARCB1 which represents a new tumor category."}, {"pubmed": 29135520, "text": "HRAS mutations were more common in epithelial-myoepithelial carcinomas (EMCAs) with intact PLAG1 and HMGA2. Most EMCAs arose ex pleomorphic adenoma (PA)and the genetic profile of EMCA varies with the absence or presence of preexisting PA and its cytogenetic signature. Progression to higher grade EMCA with intact PLAG1 and HMGA2 correlates with the presence of TP53, FBXW7 mutations, or SMARCB1 deletion."}, {"pubmed": 29222701, "text": "Study indicates that low expression of SNF5 is associated with poor prognosis in skull base chordoma."}, {"pubmed": 29230670, "text": "Data indicate that mutations affecting SMARCB1 play a role in the development or progression of a small subset of spinal schwannomas and that biallelic inactivation of SMARCB1 may cooperate with deficiency of NF2 function in schwannoma tumorigenesis."}, {"pubmed": 29280680, "text": "Review of the historical background, clinical characteristics, morphology, immunohistochemical features, and molecular genetics of SMARCB1-deficient tumors of childhood."}, {"pubmed": 29309303, "text": "Suggest that loss of expression of SWI/SNF chromatin-remodeling complex proteins has an important role in tumorigenesis in SMARCB1/INI1-preserved epithelioid sarcoma."}, {"pubmed": 29334836, "text": "Study shows that SNF5 is an upstream regulator of SATB1 in several conditions and that both are deficient in Sezary cells. SNF5 also utilizes SATB1 to recruit itself to specific sites. Overexpression of SNF5 induces SATB1 expression and partially reverse apoptosis resistance phenotype in Sezary cells. These results suggest that both SNF5 and SATB1 may regulate apoptosis-related genes in Sezary syndrome."}, {"pubmed": 29483235, "text": "MARCB1 deficiency induced GEFs for Rac GTPase activation and augmented AML cell migration and survival. Collectively, these findings highlight tumor suppressor role of SMARCB1 and illustrate SWI/SNF(Delta) function in maintaining an oncogenic gene expression program in AML."}, {"pubmed": 29625594, "text": "This is the first report of SMARCB1-deficient squamous cell carcinoma of pleura. The tumor was highly aggressive and carried a poor prognosis with short survival."}, {"pubmed": 29861296, "text": "Data show that upon suppression of SS18-SSX fusion protein, reassembly of BRG1-associated factor 47 protein (BAF47) restores enhancer activation."}, {"pubmed": 29907796, "text": "We have identified four patients with a de novo p.Arg37His PV in SMARCB1, with a distinctive phenotype different from Coffin-Siris syndrome, consisting of severe ID, hydrocephalus due to choroid plexus hyperplasia, and various additional congenital defects."}, {"pubmed": 30504402, "text": "SMARCB1 is a potential marker for distinguishing metastatic AFP-producing gastric carcinoma from Hepatocellular carcinoma."}, {"pubmed": 30860482, "text": "SMARCB1-deficient cancers rely on the ubiquitin-proteasome system which provides the foundation for a mechanism-informed clinical trial with proteasome inhibitors"}, {"pubmed": 30864974, "text": "Loss of SMARCB1 tumor suppressor function is a key oncogenic event in epithelioid malignant peripheral nerve sheath tumors."}, {"pubmed": 31043611, "text": "Study reexamine the relationship between MYC and SNF5 and show that SNF5 inhibits, not co-activate, the DNA-binding ability of MYC and impedes target gene recognition by MYC in cells. MYC regulation by SNF5 is separable from its role in chromatin remodeling, and reintroduction of SNF5 into SMARCB1-null cells mimics the primary transcriptional effects of MYC inhibition."}, {"pubmed": 31132763, "text": "Case Report: SMARCB1 (INI-1)-deficient sinonasal carcinoma can have a spectrum of morphologies and may mimic \"small-round-blue-cell\" and spindle-cell tumors on cytology preparations."}, {"pubmed": 31240424, "text": "SMARCB1 pathogenic variant in a patient with schwannomatosis and three separate synchronous primary malignancies."}, {"pubmed": 31273213, "text": "Based on study results and on the review of individuals with SMARCB1 mutations in the literature, authors suggest that the development of intellectual disability/neurodevelopmental disorders or malignant tumors could depend on a transcriptional compensation by the second intact SMARCB1 allele."}, {"pubmed": 31403913, "text": "Loss of BRG1 (SMARCA4) Immunoexpression in a Pediatric Non-Central Nervous System Tumor Cohort."}, {"pubmed": 31422588, "text": "BRG1 and INI1 loss were present in 14 of 26 cases of DDC/UDC, including 12 BRG1-deficient cases and 2 INI1-deficient cases, respectively"}, {"pubmed": 31438887, "text": "this is the first report of a SMARC-B1 deficient tumor progressing to leptomeningeal spread."}, {"pubmed": 31445842, "text": "that in differential diagnosis, cases with reduced SMARCB1/INI1 protein expression should not be excluded from a diagnosis of malignant mesothelioma"}, {"pubmed": 31502250, "text": "A deep intronic SMARCB1 variant associated with schwannomatosis."}, {"pubmed": 31567195, "text": "Compared with SMARCA4-deficient undifferentiated uterine sarcoma (SDUS), undifferentiated and dedifferentiated endometrial carcinomas (UDEC) more frequently showed TP53 mutations, microsatellite instability, and intact SMARCA4 and SMARCB1 (0% vs. 80%)."}, {"pubmed": 31732806, "text": "Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults."}, {"pubmed": 31759698, "text": "These studies unmask an evolutionarily conserved structural role for the SMARCB1 C-terminal domain that is perturbed in human disease."}, {"pubmed": 31857543, "text": "This is the first study to demonstrate loss of SMARCB1/INI1 immunoexpression in chordoid meningiomas"}, {"pubmed": 31906887, "text": "This work describes, for the first time, loss of one of the SWI/SNF ATPase subunit proteins in a large number of adenocarcinomas of the oesophagus."}, {"pubmed": 31914534, "text": "SMARCB1 (INI1)-deficient sinonasal carcinoma is mostly aggressive, with rapid progression and poor prognosis"}, {"pubmed": 32001406, "text": "To describe the current state of literature involving SMARCB1/INI-1 deficient sinonasal carcinoma (SDSC) and examine a case at our institution--{REVIEW}"}, {"pubmed": 32071317, "text": "Study identifies SWINGN, a lncRNA interacting with SMARCB1 exclusively in proliferating conditions, exerting a pro-oncogenic role in some tumor types. SWINGN is transcribed from an enhancer and modulates the activation of GAS6 oncogene as part of a topologically organized region, as well as a larger network of pro-oncogenic genes by favoring SMARCB1 binding."}, {"pubmed": 32083567, "text": "Loss of SMARCB1 expression in colon carcinoma."}, {"pubmed": 32218533, "text": "High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors."}, {"pubmed": 32244797, "text": "A Coil-to-Helix Transition Serves as a Binding Motif for hSNF5 and BAF155 Interaction."}, {"pubmed": 32306640, "text": "[Clinical and pathological analysis of 2 cases of SMARCB1(INI-1)-deficient sinonasal carcinoma]."}, {"pubmed": 32359397, "text": "Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma."}, {"pubmed": 32420340, "text": "Tumor-Suppressive Function of lncRNA-MEG3 in Glioma Cells by Regulating miR-6088/SMARCB1 Axis."}, {"pubmed": 32492816, "text": "SMARCB1 Acts as a Quiescent Gatekeeper for Cell Cycle and Immune Response in Human Cells."}, {"pubmed": 32558936, "text": "SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors."}, {"pubmed": 32576656, "text": "Sporadic vestibular schwannoma: a molecular testing summary."}, {"pubmed": 32799369, "text": "Epithelioid sarcoma with retained INI1 (SMARCB1) expression."}, {"pubmed": 32818509, "text": "Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas."}, {"pubmed": 32901946, "text": "A case of desmoplastic myxoid tumor, SMARCB1 mutant, in the pineal region."}, {"pubmed": 32910019, "text": "BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution."}, {"pubmed": 32912900, "text": "SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability."}, {"pubmed": 32940101, "text": "Role of SMARCA4 (BRG1) and SMARCB1 (INI1) in Dedifferentiated Endometrial Carcinoma With Paradoxical Aberrant Expression of MMR in the Well-Differentiated Component: A Case Report and Review of the Literature."}, {"pubmed": 33035459, "text": "Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study."}, {"pubmed": 33125876, "text": "Human Pluripotent Stem Cell Fate Regulation by SMARCB1."}, {"pubmed": 33163142, "text": "SMARCB1 Promotes Ubiquitination and Degradation of NR4A3 via Direct Interaction Driven by ROS in Vascular Endothelial Cell Injury."}, {"pubmed": 33239431, "text": "Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer."}, {"pubmed": 33331994, "text": "Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases."}, {"pubmed": 33432679, "text": "Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix."}, {"pubmed": 33481850, "text": "The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes."}, {"pubmed": 33536423, "text": "Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival."}, {"pubmed": 33581550, "text": "SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma."}, {"pubmed": 33625734, "text": "Primary cutaneous SMARCB1-deficient carcinoma."}, {"pubmed": 33658498, "text": "Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours."}, {"pubmed": 33677882, "text": "[Clinicopathological features of notochordal tumors: a study of 48 cases]."}, {"pubmed": 33931740, "text": "Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler."}, {"pubmed": 33980829, "text": "INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication."}, {"pubmed": 34003336, "text": "Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors."}, {"pubmed": 34145313, "text": "SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression."}, {"pubmed": 34265804, "text": "Vulvar Yolk Sac Tumors Are Somatically Derived SMARCB1 (INI-1)-Deficient Neoplasms."}, {"pubmed": 34273915, "text": "Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes."}, {"pubmed": 34392582, "text": "Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis."}, {"pubmed": 34609565, "text": "[SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts].\", trans \"SMARCB1(INI1)-defizientes Nierenzellkarzinom: medullar und daruber hinaus : Neue Konzepte."}, {"pubmed": 34668612, "text": "Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5."}, {"pubmed": 34719161, "text": "[Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma]."}, {"pubmed": 35123020, "text": "Clinical Diagnosis and Treatment Analyses on SMARCB1 (Integrase Interactor 1)-Deficient Sinonasal Carcinoma: Case Series with Systematic Review of the Literature."}, {"pubmed": 35446794, "text": "SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome."}, {"pubmed": 35537449, "text": "NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition."}, {"pubmed": 35758187, "text": "A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markers."}, {"pubmed": 35864317, "text": "Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms."}, {"pubmed": 36088476, "text": "The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms."}, {"pubmed": 36099437, "text": "p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition."}, {"pubmed": 36252860, "text": "ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution."}, {"pubmed": 36656230, "text": "SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge."}, {"pubmed": 36657718, "text": "SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression."}, {"pubmed": 37186844, "text": "SMARCB1 regulates the hypoxic stress response in sickle cell trait."}, {"pubmed": 37236926, "text": "SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance."}, {"pubmed": 37317642, "text": "Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors."}, {"pubmed": 37548271, "text": "Constitutional balanced translocations involving SMARCB1: A rare cause of rhabdoid tumor predisposition syndrome."}, {"pubmed": 38039617, "text": "SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum."}, {"pubmed": 38040699, "text": "SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors."}, {"pubmed": 38088461, "text": "SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases."}, {"pubmed": 38355560, "text": "The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer."}, {"pubmed": 38538798, "text": "Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF."}, {"pubmed": 38639853, "text": "Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse."}], "genomic_pos": [{"chr": "HSCHR22_1_CTG7", "end": 70878, "ensemblgene": "ENSG00000275837", "start": 23325, "strand": 1}, {"chr": "22", "end": 23838009, "ensemblgene": "ENSG00000099956", "start": 23786931, "strand": 1}], "genomic_pos_hg19": {"chr": "22", "end": 24176703, "start": 24129150, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001188", "qualifier": "involved_in", "term": "RNA polymerase I preinitiation complex assembly"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001835", "qualifier": "involved_in", "term": "blastocyst hatching"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006337", "pubmed": 8895581, "qualifier": "involved_in", "term": "nucleosome disassembly"}, {"evidence": "HDA", "gocategory": "BP", "id": "GO:0006338", "pubmed": 16217013, "qualifier": "involved_in", "term": "chromatin remodeling"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006338", "qualifier": "involved_in", "term": "chromatin remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006338", "pubmed": 11726552, "qualifier": "involved_in", "term": "chromatin remodeling"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006338", "pubmed": 22368283, "qualifier": "involved_in", "term": "chromatin remodeling"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006338", "pubmed": 10078207, "qualifier": "involved_in", "term": "chromatin remodeling"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006357", "pubmed": [8804307, 11263494, 17340523, 17920018, 18809673], "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007399", "qualifier": "involved_in", "term": "nervous system development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008285", "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0015074", "pubmed": 7801128, "qualifier": "involved_in", "term": "DNA integration"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0030071", "pubmed": [23698369, 25066234], "qualifier": "involved_in", "term": "regulation of mitotic metaphase/anaphase transition"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0039692", "pubmed": 14963118, "qualifier": "acts_upstream_of_or_within", "term": "single stranded viral RNA replication via double stranded DNA intermediate"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043923", "pubmed": 16687403, "qualifier": "involved_in", "term": "positive regulation by host of viral transcription"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0045582", "pubmed": 12110891, "qualifier": "involved_in", "term": "positive regulation of T cell differentiation"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0045597", "pubmed": [11790558, 12368262], "qualifier": "involved_in", "term": "positive regulation of cell differentiation"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0045663", "pubmed": [11175787, 15985610], "qualifier": "involved_in", "term": "positive regulation of myoblast differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045815", "pubmed": 22368283, "qualifier": "involved_in", "term": "transcription initiation-coupled chromatin remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 11950834, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051091", "pubmed": 11950834, "qualifier": "involved_in", "term": "positive regulation of DNA-binding transcription factor activity"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0070316", "pubmed": 11790558, "qualifier": "involved_in", "term": "regulation of G0 to G1 transition"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070365", "qualifier": "involved_in", "term": "hepatocyte differentiation"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1901838", "pubmed": 22368283, "qualifier": "involved_in", "term": "positive regulation of transcription of nucleolar large rRNA by RNA polymerase I"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1901838", "pubmed": 22368283, "qualifier": "involved_in", "term": "positive regulation of transcription of nucleolar large rRNA by RNA polymerase I"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:1902459", "pubmed": 19279220, "qualifier": "involved_in", "term": "positive regulation of stem cell population maintenance"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1902661", "pubmed": 22368283, "qualifier": "involved_in", "term": "positive regulation of glucose mediated signaling pathway"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:2000045", "pubmed": 10778858, "qualifier": "involved_in", "term": "regulation of G1/S transition of mitotic cell cycle"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:2000781", "pubmed": [16932743, 25066234], "qualifier": "involved_in", "term": "positive regulation of double-strand break repair"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:2000819", "pubmed": 12215535, "qualifier": "involved_in", "term": "regulation of nucleotide-excision repair"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0000228", "qualifier": "located_in", "term": "nuclear chromosome"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0000776", "pubmed": 11078522, "qualifier": "located_in", "term": "kinetochore"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0000785", "pubmed": 16217013, "qualifier": "part_of", "term": "chromatin"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0000785", "pubmed": 12192000, "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0001650", "qualifier": "located_in", "term": "fibrillar center"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0001741", "qualifier": "located_in", "term": "XY body"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [11430827, 22368283], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "pubmed": 22368283, "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016363", "pubmed": 9128241, "qualifier": "located_in", "term": "nuclear matrix"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016514", "pubmed": [8804307, 8895581, 11078522], "qualifier": "part_of", "term": "SWI/SNF complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016514", "pubmed": 8804307, "qualifier": "part_of", "term": "SWI/SNF complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016586", "pubmed": 8804307, "qualifier": "part_of", "term": "RSC-type complex"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0032991", "pubmed": 16217013, "qualifier": "part_of", "term": "protein-containing complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0035060", "qualifier": "part_of", "term": "brahma complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0035060", "pubmed": 8804307, "qualifier": "part_of", "term": "brahma complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043073", "qualifier": "located_in", "term": "germ cell nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "located_in", "term": "intracellular membrane-bounded organelle"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0071564", "qualifier": "part_of", "term": "npBAF complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0071564", "qualifier": "part_of", "term": "npBAF complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0071564", "pubmed": 8804307, "qualifier": "part_of", "term": "npBAF complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0071565", "qualifier": "part_of", "term": "nBAF complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0071565", "qualifier": "part_of", "term": "nBAF complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0071565", "pubmed": 17920018, "qualifier": "part_of", "term": "nBAF complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0140092", "pubmed": 12368262, "qualifier": "part_of", "term": "bBAF complex"}], "MF": [{"category": "MF", "evidence": "IMP", "id": "GO:0001164", "pubmed": 22368283, "qualifier": "contributes_to", "term": "RNA polymerase I core promoter sequence-specific DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0002039", "pubmed": 11950834, "qualifier": "enables", "term": "p53 binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003677", "pubmed": 26073604, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003713", "qualifier": "enables", "term": "transcription coactivator activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0003713", "pubmed": 16687403, "qualifier": "enables", "term": "transcription coactivator activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10078207, 12368262, 14963118, 15985610, 16601680, 16687403, 20111005, 21900206, 22368283, 23540691, 24874740, 24981860, 27229929, 30108113, 31759698, 32814053, 34591612], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0030957", "pubmed": 16687403, "qualifier": "enables", "term": "Tat protein binding"}, {"category": "MF", "evidence": "HDA", "id": "GO:0031492", "pubmed": 16217013, "qualifier": "contributes_to", "term": "nucleosomal DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [27229929, 30108113], "qualifier": "enables", "term": "identical protein binding"}]}, "homologene": {"genes": [[6239, 175571], [7165, 1282012], [7227, 40657], [7955, 799716], [8364, 448543], [9031, 769489], [9544, 699190], [9598, 458702], [9606, 6598], [9615, 486407], [9913, 537412], [10090, 20587], [10116, 361825]], "id": 2310}, "interpro": [{"desc": "SNF5/SMARCB1/INI1", "id": "IPR006939", "short_desc": "SNF5"}, {"desc": "Chromatin-remodeling complex component Sfh1/SNF5", "id": "IPR017393", "short_desc": "Sfh1/SNF5"}, {"desc": "SWI/SNF Subunit INI1, DNA binding domain", "id": "IPR048664", "short_desc": "INI1_DNA-bd"}], "ipi": ["IPI00029695", "IPI00303439", "IPI00745019", "IPI00879096", "IPI00879156"], "map_location": "22q11.23|22q11", "name": "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1", "other_names": ["BRG1-associated factor 47", "SNF5 homolog", "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1", "SWI/SNF-related matrix-associated protein", "hSNF5", "integrase interactor 1 protein", "malignant rhabdoid tumor suppressor", "protein phosphatase 1, regulatory subunit 144", "sucrose nonfermenting, yeast, homolog-like 1"], "pantherdb": {"HGNC": "11103", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1328366", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 10090, "uniprot_kb": "Q9Z0H3"}, {"RGD": "1308761", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 10116, "uniprot_kb": "Q4KLI0"}, {"Ensembl": "ENSGALG00000005983", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 9031, "uniprot_kb": "Q5ZK40"}, {"ZFIN": "ZDB-GENE-041114-5", "ortholog_type": "O", "panther_family": "PTHR10019", "taxid": 7955, "uniprot_kb": "Q5U379"}, {"ZFIN": "ZDB-GENE-991008-16", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 7955, "uniprot_kb": "A0A2R8QP61"}, {"WormBase": "WBGene00011111", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 6239, "uniprot_kb": "Q21831"}, {"FlyBase": "FBgn0011715", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 7227, "uniprot_kb": "Q24090"}, {"SGD": "S000004313", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 4932, "uniprot_kb": "Q06168"}, {"PomBase": "SPCC16A11.14", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 4896, "uniprot_kb": "Q9USM3"}, {"PomBase": "SPAC2F7.08c", "ortholog_type": "O", "panther_family": "PTHR10019", "taxid": 4896, "uniprot_kb": "Q09699"}, {"dictyBase": "DDB_G0279373", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 352472, "uniprot_kb": "Q54WV6"}, {"EnsemblGenome": "AT3G17590", "ortholog_type": "LDO", "panther_family": "PTHR10019", "taxid": 3702, "uniprot_kb": "P93045"}], "uniprot_kb": "Q12824"}, "pathway": {"biocarta": [{"id": "hswisnfpathway", "name": "chromatin remodeling by hswi/snf atp-dependent complexes"}, {"id": "pcafpathway", "name": "the information processing pathway at the ifn beta enhancer"}], "kegg": [{"id": "hsa04714", "name": "Thermogenesis - Homo sapiens (human)"}, {"id": "hsa05225", "name": "Hepatocellular carcinoma - Homo sapiens (human)"}], "netpath": {"id": "Pathway_TNFalpha", "name": "TNFalpha"}, "pid": [{"id": "erb_genomic_pathway", "name": "Validated nuclear estrogen receptor beta network"}, {"id": "rb_1pathway", "name": "Regulation of retinoblastoma protein"}], "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-212165", "name": "Epigenetic regulation of gene expression"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-3214858", "name": "RMTs methylate histone arginines"}, {"id": "R-HSA-3247509", "name": "Chromatin modifying enzymes"}, {"id": "R-HSA-4839726", "name": "Chromatin organization"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8878171", "name": "Transcriptional regulation by RUNX1"}, {"id": "R-HSA-8939243", "name": "RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"}, {"id": "R-HSA-9730414", "name": "MITF-M-regulated melanocyte development"}, {"id": "R-HSA-9730414", "name": "MITF-M-regulated melanocyte development"}, {"id": "R-HSA-9824585", "name": "Regulation of MITF-M-dependent genes involved in pigmentation"}, {"id": "R-HSA-9824585", "name": "Regulation of MITF-M-dependent genes involved in pigmentation"}, {"id": "R-HSA-9842860", "name": "Regulation of endogenous retroelements"}, {"id": "R-HSA-9845323", "name": "Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)"}, {"id": "R-HSA-9856651", "name": "MITF-M-dependent gene expression"}, {"id": "R-HSA-9856651", "name": "MITF-M-dependent gene expression"}], "wikipathways": [{"id": "WP4204", "name": "Tumor suppressor activity of SMARCB1"}, {"id": "WP4321", "name": "Thermogenesis"}, {"id": "WP5072", "name": "Modulators of TCR signaling and T cell activation"}]}, "pdb": ["5AJ1", "5GJK", "5L7A", "5L7B", "6AX5", "6KAG", "6KZ7", "6LTH", "6LTJ", "6LZP", "6UCH", "7VDV", "7Y8R"], "pfam": ["PF04855", "PF21459"], "pharmgkb": "PA35953", "pharos": {"target_id": 3811, "tdl": "Tbio"}, "pir": "S54705", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF176889", "relationship": "is"}, {"id": "GNF187795", "relationship": "is"}, {"id": "GNF198701", "relationship": "is"}, {"id": "GNF209607", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF031068", "relationship": "similar to"}, {"id": "GNF048120", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF113705", "relationship": "is"}, {"id": "GNF153346", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000022.11", "NC_060946.1", "NG_009303.1", "NT_187633.1"], "protein": ["NP_001007469.1", "NP_001304875.1", "NP_001349806.1", "NP_003064.2"], "rna": ["NM_001007468.3", "NM_001317946.2", "NM_001362877.2", "NM_003073.5"], "translation": [{"protein": "NP_001349806.1", "rna": "NM_001362877.2"}, {"protein": "NP_001007469.1", "rna": "NM_001007468.3"}, {"protein": "NP_003064.2", "rna": "NM_003073.5"}, {"protein": "NP_001304875.1", "rna": "NM_001317946.2"}]}, "reporter": {"HG-U133_Plus_2": ["212167_s_at", "228898_s_at"], "HG-U95Av2": "40416_at", "HTA-2_0": "TC22000139.hg.1", "HuEx-1_0": "3939365", "HuGene-1_1": "8071768", "HuGene-2_1": "16928046"}, "summary": "The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015].", "symbol": "SMARCB1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C0812273"}, "unigene": "Hs.534350", "uniprot": {"Swiss-Prot": "Q12824", "TrEMBL": ["Q9H836", "G5E975", "A0A0G2JRV3", "A0A0G2JSE9", "B5MCL5", "A0A0U1RQQ2", "A0A2R8YEE8", "A0A2R8YDN6", "A0A2R8Y5Z2", "C9JTA6", "A0A2R8Y5N5", "A0A0U1RRB8"]}, "wikipedia": {"url_stub": "SMARCB1"}}